On the Evolutionary Advantage of Coagulation Factor V Leiden (FVL)

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|22|32|3676-3681

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.22, Iss.32, 2015-10, pp. : 3676-3681

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Carriership of Factor V Leiden and Evolutionary Selection Advantage

By  

Current Medicinal Chemistry, Vol. 15, Iss. 15, 2008-06 ,pp. : 1541-1544

Bentham Science Publishers

Access to resources Recommend Favorite

Screening justified for relatives of factor V Leiden carriers

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 565, 2008-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

The Role of Factor V Leiden in Maternal Health and the Outcome of Pregnancy

By  

Current Drug Targets, Vol. 6, Iss. 5, 2005-08 ,pp. : 567-576

Bentham Science Publishers

Access to resources Recommend Favorite

Phenylephrine: Cutaneous microvascular occlusion syndrome in a patient with a heterozygous factor V Leiden mutation: case report

By  

Reactions Weekly, Vol. 1, Iss. 1178, 2007-01 ,pp. : 30-30

Adis International

Access to resources Recommend Favorite

Sunitinib: Thrombotic microangiopathy, proteinuria and hypertension in a patient with factor V Leiden mutation: case report

By  

Reactions Weekly, Vol. 1, Iss. 1204, 2008-01 ,pp. : 31-32

Adis International

Access to resources Recommend Favorite